Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNa in chronic myeloid leukemia cells

Shan Zhu; Lizhi Cao; Yan Yu; Liangchun Yang; Minghua Yang; Ke Liu; Jun Huang; Rui Kang; Livesey, Kristen M.; Tang, Daolin
March 2013
Autophagy;Mar2013, Vol. 9 Issue 3, p317
Academic Journal
No abstract available.


Related Articles

  • Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia. El-Khoury, V; Pierson, S; Szwarcbart, E; Brons, N H C; Roland, O; Cherrier-De Wilde, S; Plawny, L; Van Dyck, E; Berchem, G // Leukemia (08876924);Aug2014, Vol. 28 Issue 8, p1636 

    Evading apoptosis is a hallmark of B-cell chronic lymphocytic leukemia (CLL) cells and an obstacle to current chemotherapeutic approaches. Inhibiting histone deacetylase (HDAC) has emerged as a promising strategy to induce cell death in malignant cells. We have previously reported that the HDAC...

  • Wogonin induces Beclin-1/PI3K and reactive oxygen species-mediated autophagy in human pancreatic cancer cells. SHAO-JUN LI; SHI-JIE SUN; JIE GAO; FU-BO SUN // Oncology Letters;Dec2016, Vol. 12 Issue 6, p5059 

    Wogonin is considered to be an inhibitor of myeloid cell leukemia 1 and B-cell lymphoma 2, and a potential antitumor drug due to its ability to induce apoptosis in certain cancer cells; however, few previous studies have reported on wogonin-induced autophagy. The aim of the present study was to...

  • Erratum.  // Journal of Clinical Investigation;Mar2011, Vol. 121 Issue 3, p1222 

    A correction to the article "Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity" that was published in the 2011 issue is presented.

  • HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Liu, L.; Yang, M.; Kang, R.; Wang, Z.; Zhao, Y.; Yu, Y.; Xie, M.; Yin, X.; Livesey, K. M.; Lotze, M. T.; Tang, D.; Cao, L. // Leukemia (08876924);Jan2011, Vol. 25 Issue 1, p23 

    Autophagy, a tightly regulated lysosome-dependent catabolic pathway, is important in the regulation of cancer development and progression and in determining the response of tumor cells to anticancer therapy. However, the role of autophagy in leukemia still remains largely unknown. Here we show...

  • Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. Dong, Xiaofeng; Li, Rui; Xiu, Peng; Dong, Xuesong; Xu, Zongzhen; Zhai, Bo; Liu, Feng; Jiang, Hongchi; Sun, Xueying; Li, Jie; Qiao, Haiquan // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: Cyclooxygenase (COX)-2 is overexpressed in many types of cancers including hepatocellular carcinoma (HCC). Meloxicam, a selective COX-2 inhibitor, has shown potential therapeutic effects against HCC, but the mechanisms accounting for its anti-cancer activities remain unclear. Methods...

  • Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Stankov, M V; El Khatib, M; Kumar Thakur, B; Heitmann, K; Panayotova-Dimitrova, D; Schoening, J; Bourquin, J P; Schweitzer, N; Leverkus, M; Welte, K; Reinhardt, D; Li, Z; Orkin, S H; Behrens, G M N; Klusmann, J H // Leukemia (08876924);Mar2014, Vol. 28 Issue 3, p577 

    Histone deacetylase (HDAC) inhibitors (HDACis) are well-characterized anti-cancer agents with promising results in clinical trials. However, mechanistically little is known regarding their selectivity in killing malignant cells while sparing normal cells. Gene expression-based chemical genomics...

  • Paraptosis Cell Death Induction by the Thiamine Analog Benfotiamine in Leukemia Cells. Sugimori, Naomi; Espinoza, J. Luis; Trung, Ly Quoc; Takami, Akiyoshi; Kondo, Yukio; An, Dao Thi; Sasaki, Motoko; Wakayama, Tomohiko; Nakao, Shinji // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Benfotiamine is a synthetic thiamine analogue that stimulates transketolase, a cellular enzyme essential for glucose metabolism. Currently, benfotiamine is used to treat diabetic neuropathy. We recently reported that oral benfotiamine induced a temporary but remarkable recovery from acute...

  • The Importance of Autophagy Regulation in Breast Cancer Development and Treatment. Zarzynska, Joanna Magdalena // BioMed Research International;2014, Vol. 2014, p1 

    Breast cancer (BC) is a potentially life-threatening malignant tumor that still causes high mortality among women. One of the mechanisms through which cancer development could be controlled is autophagy. This process exerts different effects during the stages of cancer initiation and progression...

  • Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells. Weidong Han; Jie Sun; Lifeng Feng; KaiFeng Wang; Da Li; Qin Pan; Yan Chen; Wei Jin; Xian Wang; Hongming Pan; Hongchuan Jin // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    Anthracycline daunorubicin (DNR) is one of the major antitumor agents widely used in the treatment of myeloid leukemia. Unfortunately, the clinical efficacy of DNR was limited because of its cytotoxity at high dosage. As a novel cytoprotective mechanism for tumor cell to survive under...

  • Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro. Tong, Yin; Liu, Yan-yan; You, Liang-shun; Qian, Wen-bin // Acta Pharmacologica Sinica;Apr2012, Vol. 33 Issue 4, p542 

    Aim:The efficacy of the Akt inhibitor perifosine against chronic myeloid leukemia (CML) cells and its mechanisms of action are unknown. In this study, the cytotoxic effects of perifosine on CML and acute myeloid leukemia (AML) cell lines were compared to elucidate the mechanisms underlying the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics